Although many aspects of the APP/PS1 AD-like phenotype improved in one or both knockout mice, the rescue was not as dramatic as seen with the At-1S113R/+ or compound 9 (Atase1/Atase2 inhibitor) treatment. Here, NAT8 is linked to Alzheimer disease.